Hill-Rom Holdings Inc (HRC) has an average broker rating of 1.75, which is interpreted as a Buy, as rated by 6 equity analysts. Nonetheless, 3 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 1 other analysts advise a Buy. Nevertheless, the majority of 2 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 2, which is also a Buy.
Hill-Rom Holdings Inc (HRC) stock is expected to deviate a maximum of $4.35 from the average target price of $65.25 for the short term period. 4 Street Experts have initiated coverage on the stock with the most promising target being $69 and the most muted being $59.
For the current week, the company shares have a recommendation consensus of Buy. Also, Brokerage firm Morgan Stanley upgrades its rating on Hill-Rom Holdings Inc (NYSE:HRC). As per the latest information, the brokerage house raises the price target to $62 per share from a prior target of $54. The shares have been rated Overweight. Previously, the analysts had a Equal-weight rating on the shares. The rating by the firm was issued on June 16, 2016.
Hill-Rom Holdings Inc (NYSE:HRC): stock was range-bound between the intraday low of $59.7 and the intraday high of $60.42 after having opened at $60.26 on Wednesdays session. The stock finally closed in the red at $60.26, a loss of -0.43%. The stock remained in the red for the whole trading day. The total traded volume was 611,013 shares. The stock failed to cross $60.42 in Wednesdays trading. The stocks closing price on Thursday was $60.24.
Hill-Rom Holdings, Inc. (Hill-Rom) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. The Company operates in three segments: North America, Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services, as well as its clinical workflow solutions, in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.